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Abstract
The ubiquitin proteasome system plays a role in regulating protein activity and is integral to the
turnover of damaged and worn proteins. In this review, we discuss the recently described
relationship between the ubiquitin proteasome system and the cardiac creatine kinase/phospho-
creatine shuttle, an essential component of ATP generation and energy shuttling within the heart.
The ubiquitin ligase muscle ring finger-1 (MuRF1) binds creatine kinase, leading to its
ubiquitination and possible degradation. MuRF1 may also be integral in the regulation of creatine
kinase activity in vivo. Since there is a close relationship between the cardiac creatine kinase/
phospho-creatine shuttle activity and heart failure, these findings suggest that MuRF1’s role in
protein quality control of creatine kinase may be vital to the regulation and maintenance of cardiac
energetics to protect against heart failure.
Introduction
The demand for intracellular ATP is approximately 10,000 times greater than the actual
amount of ATP present in cells (Ingwall 2009), resulting in the need for highly energetic
cells like cardiomyocytes to regenerate ATP so as to maintain pump function. The
regeneration of ATP is maintained, in part, by the oxidation of fatty acids and glucose.
During cardiac stress, additional pathways are also utilized, including glycolysis and
phosphotransferase systems mediated by creatine kinase (CK) and adenylate kinase. The
phosphotransferase system also acts as a metabolic relay, transferring ATP between its site
of production (mitochondria) and its site of utilization (e.g. sarcomere). The fact that the
regulation of these systems changes in response to the available energy supply has been
known for some time. However, our knowledge of the mechanism by which this regulation
occurs is relatively sparse. In this review, we discuss recent studies identifying the role of
the ubiquitin ligase muscle ring finger-1 (MuRF1) in the protein quality control of the
phosphotransferase system mediated by CK. A clearer understanding of how these systems
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are regulated may offer insight into both the pathogenesis of and potential new therapies for
heart failure.
The ubiquitin proteasome system (UPS) and protein quality control
Protein turnover and the degradation of specific proteins are essential for regulating every
aspect of cellular function. In eukaryotic cells, the ubiquitin proteasome system (UPS)
selectively tags proteins with covalently-linked ubiquitin for degradation by the proteasome
(see Figure 1). The UPS serves two major roles: 1) regulating protein function; and 2)
regulating protein quality control. UPS-mediated degradation is essential in regulating key
cellular processes such as apoptosis and cell cycle (Pines 2006). Likewise, during periods of
hypoxic stress within the cell, the UPS-regulates degradation of transcription factors such as
HIF1α in an oxygen-dependent manner (Jaakkola et al. 2001). The UPS is also important for
regulating protein quality control. The UPS recognizes and degrades misfolded proteins that
accrue within the cell owing to the “wear and tear” that occurs during the normal
homeostasis of cellular processes. Recently it has also been suggested that post-translational
modification and damage may be a signal for protein degradation by the UPS. For example,
mildly oxidized proteins are degraded by the proteasome (Dunlop et al. 2009), suggesting
that oxidative changes to proteins, such as carbonylation, may be one signal that elicits the
recognition by ubiquitin ligases to target specific proteins for destruction. Furthermore,
evidence for UPS-involvement in the maintenance of the creatine kinase/phospho-creatine
system has also recently been demonstrated.
The creatine kinase/phospho-creatine (CK/PCr) system
The CK/PCr is a buffering system essential for cells that have a high and fluctuating energy
requirement, such as myocytes. It connects the site of ATP production (mitochondria) with
those sites where energy is needed (for example the sarcomere; Figure 2). The CK enzyme
transfers the N-phosphoryl group from phospho-creatine (PCr) to ADP to regenerate ATP
(Figure 2A and 2B). There are four isoenzymes of CK, whose names are derived from their
original source of isolation: CK-MM derived from muscle; CK-BB derived from brain; CK-
MB found in the heart and mtCK derived from mitochondria. The CK-MM isoform exists
within myofibrils as part of the structures localized to the M-band and is functionally
coupled to myosin ATPase, allowing for the efficient maintenance of high ATP/ADP
locally, stimulation of ATPase activity and assurance of proper contraction of the muscle
(Ventura-Clapier et al. 1994).
The ubiquitin ligase MuRF1 regulates CK protein quality control and
activity
MuRF family proteins are mechanically responsive proteins that have been implicated in
various aspect of contractile regulation and myogenic responses (Hoshijima 2006). MuRF
family members have RING finger motifs that have demonstrated ubiquitin ligase (E3)
activity targeted to a number of adjacent sarcomere proteins including troponin I, myosin
binding protein and myosin binding protein-C (Kedar et al. 2004). More recently, a yeast
two-hybrid screening of skeletal muscle cDNA libraries using full length human MuRF1 as
bait revealed that MuRF-1 interacts with muscle enzymes involved with metabolism such as
muscle CK and adenylate kinase 1, both key regulators of ATP transfer in the cell (Witt et
al. 2005). The results of these studies suggested that MuRF1 might modulate metabolism by
directly interacting with key regulatory enzymes. This hypothesis paved the way for further
investigation into the mechanism by which MuRF1 regulates cardiac function during stress.
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MuRF1 preferentially ubiquitinates oxidized CK
In vitro ubiquitination assays led to the discovery that MuRF1 has the ability to ubiquitinate
CK (Zhao et al. 2007). More importantly though, this reaction is enhanced in the setting of
oxidation, suggesting that the cell preferentially targets the oxidized form of CK-MM for
degradation. This is a fascinating finding and hints at a possible quality control mechanism
within the cell. In order to target the regeneration of ATP to the area in most need of this
energy supply, CK-MM specifically binds to the M-line of the sarcomere via an interaction
with myomesin. When the ability of wild-type versus oxidized CK-MM to bind to
myomesin was investigated, it was discovered that once CK-MM is oxidized it loses it
ability to integrate into the M-line. Since the M-line-bound CK-MM is crucial for ATP
production, particularly during times of stress, one conclusion for the preferred
ubiquitination of oxidized CK-MM is that this isoform is targeted for degradation so as to
increase the amount of functional CK-MM in the cell.
Chronic ectopic expression of high levels of cardiac MuRF1 increases susceptibility to
heart failure in response to pressure overload in vivo
Several lines of evidence suggest that MuRF1 acts to inhibit cardiac hypertrophy (Arya et al.
2004;Willis et al. 2007). We created transgenic mice constitutively expressing increased
cardiac levels of MuRF1 (MuRF1 Tg+ mice) to further elucidate the possible underlying
mechanisms of MuRF1’s regulation of cardiac hypertrophy (Willis et al. 2009b). MuRF1 Tg
+ and wild-type mice appear to have little or no functional differences by catheter analysis
in vivo. Surprisingly though, the increased expression of cardiac MuRF1 in the MuRF1 Tg+
mice does not save these mice from developing cardiac hypertrophy in response to trans-
aortic cuffing (TAC; Willis et al. 2009b). In fact, these mice develop an eccentric pattern of
hypertrophy that rapidly progresses to heart failure within 4 weeks following TAC with
thinning of the anterior and posterior walls, dilation of the left ventricle and a 70% decrease
in fractional shortening compared to wild-type mice (Willis et al. 2009b). These results were
surprising and indicated that MuRF1’s regulation of cardiac hypertrophy is likely to be
multifactorial in nature with and possibly numerous biochemical mechanisms involved.
MuRF1 regulates cardiac CK in vivo
The rapid failure of MuRF1 Tg+ mouse hearts in response to pressure overload from TAC,
along with the data demonstrating that MuRF1 interacts with CK and ubiquitinates it in
vitro(Koyama et al. 2008;Witt et al. 2005;Zhao et al. 2007), suggested that MuRF1’s
involvement in cardiac regulation may be tied to the metabolic pathways involving CK. This
hypothesis was supported by the finding that MuRF1 Tg+ mouse hearts exhibit a ~20–25%
decrease in total CK activity in vitro compared to wild-type animals, both at baseline and
after TAC. Despite this decrease in CK activity, the level of total ATP in MuRF1 Tg+ hearts
does not significantly differ from wild type mice at baseline or after TAC. Likewise, western
blot analysis of the levels of the various CK isoforms (CK-M, CK-B and CK-Mt) in MuRF1
Tg+ or wild-type mouse hearts reveals no differences at baseline or after 4 weeks TAC,
suggesting that MuRF1 does not affect the steady state levels of CK.
Interestingly though, despite not seeing changes in steady state cardiac CK levels, MuRF1
Tg+ mouse hearts do exhibit evidence of enhanced post-translational modification of CK-M/
B entities (Willis et al. 2009b). Recent studies have demonstrated that post-translational
modification of CK and adenylate kinase 1 can occur with S-nitrosylation (addition of a NO
group), leading to inhibition of activity by possible upstream signaling through NO (Shi et
al. 2008). CK activity has also been shown to be regulated by reversible phosphorylation in
the heart and skeletal muscle (Dieni and Storey 2009). Therefore, it is possible that
MuRF1’s interaction with CK results in the post-translational modifications seen, thereby
accounting for the decreased CK activity in MuRF1 Tg+ mouse hearts. This novel role for
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MuRF1 would be in line with the fact that the UPS is instrumental in regulating protein
activity in addition to its role in targeting proteins for degradation (Kedar et al. 2004). It
could also offer an explanation for why there is no heightened CK degradation in the
presence of increased MuRF1 expression in the MuRF1 Tg+ mouse hearts, even though
there is evidence that MuRF1 ubiquitinates CK in vitro(Koyama et al. 2008;Zhao et al.
2007). An alternative explanation for the lack of CK degradation in these mice is an increase
in de-ubiquitinating activity in compensation for the constitutive MuRF1 expression in the
MuRF1 Tg + heart (Figure 2D), a proposition that has yet to be tested.
While studies of MuRF1 expression in the heart using the MuRF1 Tg+ animals have been
helpful in determining the downstream functions MuRF1 regulates, there are some
weaknesses to this approach. First, it is not clear how physiologically relevant the chronic
45-fold increase in cardiac MuRF1 expression that is found in these mice is (Willis et al.
2009b). To date, the largest in vivo increase in MuRF1 protein expression is only 2-fold and
has been reported to occur in response to ischemia or LVAD implantation (Adams et al.
2008;Willis et al. 2009a). Furthermore, the increases in MuRF1 expression that have been
reported have been transient, not constitutive in nature, as in the case of the MuRF1 Tg+
mice (Adams et al. 2008). Complicating the picture more is the debate of the role of CK in
heart failure. CK-deficient mice are prone to develop heart failure when challenged with
increased workloads (Boehm et al. 2000) but appear normal at baseline, quite similar to the
MuRF1 Tg+ mice (Willis et al. 2009b). While reduced CK activity contributes to impaired
contractile reserves (Ingwall 2009), it is not necessarily entirely responsible for the
decreased contractility found in heart failure. For example, other key phosphotransferase
systems and enzymatic regulation of substrate utilization also appear to be affected (Dzeja et
al. 2000;Ingwall 2009). Similarly, the increased susceptibility of MuRF1 Tg+ hearts to heart
failure in response to pressure overload may not be caused directly through MuRF1’s effects
on CK. Chronic increase in cardiac MuRF1 does result in significant changes in genes
regulating oxidative phosphorylation (such as PGC-1) and the TCA cycle at the mRNA level
(Willis et al. 2009b). Similarly, mice lacking MuRF1 undergo an exaggerated pathological
cardiac hypertrophy in response to TAC, suggesting an essential need for MuRF1 in normal
cardiac regulation. Therefore, the balance between a healthy heart, cardiac hypertrophy, and
heart failure may come down to a tightly regulated titration of MuRF1 protein expression.
With this in mind, it may be possible to therapeutically regulate MuRF1 levels to target
critical metabolic functions. However, these ideas have yet to be tested.
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Glossary
AMPK AMP-activated protein kinase
CK creatine kinase
MuRF1 Muscle Ring Finger-1
CK/PCr Creatine kinase/Phospho-Creatine
CK-BB creatine kinase isoform with two B subunits
CK-MB creatine kinase isoform with M and B subunits
CK-MM creatine kinase isoform with two M subunits
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CK-M/B creatine kinase isoform with M and/or B subunits
E1 ubiquitin activating enzyme
E2 ubiquitin conjugating enzyme
E3 ubiquitin ligase
mtCK mitochondrial creatine kinase isoform
MuRF1 Tg+ MuRF1 transgenic
UPS ubiquitin proteasome system
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The canonical Ubiquitin Proteasome System (UPS). Protein ubiquitination is driven by the
action of 3 successive enzymes. The ubiquitin-activating enzyme (E1) activates ubiquitin in
an ATP-dependent manner, adding the ubiquitin to the subsequent ubiquitin conjugating
(E2) enzyme. Ubiquitin is then transferred from the ubiquitin-charged E2 to the substrate
and/or the growing ubiquitin chain by the activity of a ubiquitin ligase (E3), which gives the
system specificity. The multi-ubiquitin chain attached to the substrate is recognized by the
26S proteasome, which degrades the substrate and ubiquitin chain. The selective nature of
the ubiquitin ligases is the focus of many investigations since it drives the specificity of the
reaction. The canonical UPS degradation system shown here represents a skeletal schematic
for a much more complex system, with ancillary factors participating in substrate
recognition and a pathway involved in regulating protein activities by post-translational
modifications that don’t always lead to degradation (Elsasser et al. 2004;Li et al.
2007;Richly et al. 2005).
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MuRF1’s regulation of CK activity in the heart and its effects on energy transfer. A. ATP
(Energy) production. The metabolism of fatty acid and glucose leads to the production of
ATP in the mitochondria via oxidative phosphorylation. B. ATP/Energy transfer by the
Phospho-Creatine (PCr) Shuttle. The PCr shuttle transfers ATP by transferring high energy
phosphates on to and off of creatine through the CK isoforms mtCK and CK-M/B. CK
isoforms can be compartmentalized at specific intracellular sites or can be found free in the
cytosol. The CK-MM isoform has been identified in myofibrils as part of the structures
localized to the M band (Wallimann and Eppenberger 1985). C. ATP utilization by
ATPases. CK-M/B localized adjacent to ATPases utilize ATP to perform work, such as
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sarcomere/muscle contraction, electromechanical coupling, and action potentials. The CK-
MM is functionally coupled to the myosin ATPase, allowing the efficient maintenance of
high ATP/ADP locally, stimulating ATPase activity and ensuring proper contraction of the
muscle (Ventura-Clapier et al. 1994). CK-MM is also bound to the membranes of the
sarcoplasmic reticulum, where it is coupled functionally to Ca2+-ATPase (Minajeva et al.
1996;Rossi et al. 1990), ensuring efficient energy provision of local generation of ATP. A
smaller amount of CK-MM is associated with Na+/K+-ATPase (Wallimann et al. 1989). D.
The ubiquitin proteasome system (UPS) in protein quality control. The UPS, including E1,
E2, and E3’s such as MuRF1, interact and ubiquitinate CK, likely targeting the substrates for
degradation in a dynamic process of protein quality control. Adapted from: Zhou 2005
(Zhao et al. 2007) and Willis (Willis and Patterson 2006).
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